300869 康泰医学
已收盘 04-03 15:00:00
资讯
新帖
简况
康泰医学:目前公司聚焦主营业务发展,持续深耕现有核心业务领域
证券之星 · 02-26
康泰医学:目前公司聚焦主营业务发展,持续深耕现有核心业务领域
康泰医学:公司在“互联网+医疗健康”领域不断探索合适的业务场景切入点
证券之星 · 02-19
康泰医学:公司在“互联网+医疗健康”领域不断探索合适的业务场景切入点
康泰医学新注册《CMS-ENMS心电及电生理网络管理系统软件V1.0》等2个项目的软件著作权
证券之星 · 02-18
康泰医学新注册《CMS-ENMS心电及电生理网络管理系统软件V1.0》等2个项目的软件著作权
康泰医学:目前公司正在对相关产品进行考察
证券之星 · 02-18
康泰医学:目前公司正在对相关产品进行考察
康泰医学获得实用新型专利授权:“医疗支架装置”
证券之星 · 02-14
康泰医学获得实用新型专利授权:“医疗支架装置”
康泰医学获得外观设计专利授权:“止痒仪”
证券之星 · 02-14
康泰医学获得外观设计专利授权:“止痒仪”
康泰医学获得实用新型专利授权:“吸奶器主机及吸奶器”
证券之星 · 02-14
康泰医学获得实用新型专利授权:“吸奶器主机及吸奶器”
康泰医学新注册《PM10便携式心电计软件V1.7》等2个项目的软件著作权
证券之星 · 02-10
康泰医学新注册《PM10便携式心电计软件V1.7》等2个项目的软件著作权
康泰医学新注册《NE-M01VET兽用雾化器软件V1.4》等70个项目的软件著作权
证券之星 · 01-21
康泰医学新注册《NE-M01VET兽用雾化器软件V1.4》等70个项目的软件著作权
康泰医学:预计2024年全年扣非后净利润亏损7400万元至1.25亿元
证券之星 · 01-17
康泰医学:预计2024年全年扣非后净利润亏损7400万元至1.25亿元
康泰医学(300869.SZ)发预亏,预计2024年度净亏损5500万元–1.05亿元,由盈转亏
智通财经 · 01-17
康泰医学(300869.SZ)发预亏,预计2024年度净亏损5500万元–1.05亿元,由盈转亏
康泰医学:预计2024年净利润亏损5500万元–1.05亿元
美港电讯 · 01-17
康泰医学:预计2024年净利润亏损5500万元–1.05亿元
康泰医学新注册《康泰SP770VET兽用输液泵嵌入式软件V1.0》等12个项目的软件著作权
证券之星 · 01-13
康泰医学新注册《康泰SP770VET兽用输液泵嵌入式软件V1.0》等12个项目的软件著作权
康泰医学新注册《康泰PM20便携式心电计嵌入式软件V1.0》等3个项目的软件著作权
证券之星 · 01-10
康泰医学新注册《康泰PM20便携式心电计嵌入式软件V1.0》等3个项目的软件著作权
康泰医学最新公告:收到美国伊利诺伊北区联邦地区法院出具的《约定的永久禁令与撤诉令》
证券之星 · 01-10
康泰医学最新公告:收到美国伊利诺伊北区联邦地区法院出具的《约定的永久禁令与撤诉令》
康泰医学新注册《康泰超声骨密度仪PC软件V1.0》等4个项目的软件著作权
证券之星 · 01-07
康泰医学新注册《康泰超声骨密度仪PC软件V1.0》等4个项目的软件著作权
康泰医学新注册《康泰SP100A/SP100B肺功能仪嵌入式软件V3.4》项目的软件著作权
证券之星 · 01-06
康泰医学新注册《康泰SP100A/SP100B肺功能仪嵌入式软件V3.4》项目的软件著作权
康泰医学新注册《康泰AP100空气波按摩仪嵌入式软件V1.0》等2个项目的软件著作权
证券之星 · 01-04
康泰医学新注册《康泰AP100空气波按摩仪嵌入式软件V1.0》等2个项目的软件著作权
加载更多
公司概况
公司名称:
康泰医学系统(秦皇岛)股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-08-24
主营业务:
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。
发行价格:
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":14.58,"timestamp":1743663798000,"preClose":14.54,"halted":0,"volume":7182516,"delay":0,"changeRate":0.0028,"floatShares":252999999,"shares":401999999,"eps":-0.0485,"marketStatus":"已收盘","change":0.04,"latestTime":"04-03 15:00:00","open":14.54,"high":15.16,"low":14.45,"amount":106000000,"amplitude":0.0488,"askPrice":14.58,"askSize":127,"bidPrice":14.57,"bidSize":171,"shortable":0,"etf":0,"ttmEps":-0.0485,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.54,"symbolType":"stock","openAndCloseTimeList":[[1743643800000,1743651000000],[1743656400000,1743663600000]],"highLimit":15.99,"lowLimit":13.09,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401802977,"isCdr":false,"pbRate":3.07,"roa":"--","roe":"0.5%","epsLYR":0.41,"committee":0.004886,"marketValue":5858000000,"turnoverRate":0.0283,"status":0,"floatMarketCap":3694000000},"requestUrl":"/m/hq/s/300869","defaultTab":"news","newsList":[{"id":"2514817758","title":"康泰医学:目前公司聚焦主营业务发展,持续深耕现有核心业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2514817758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514817758?lang=zh_cn&edition=full","pubTime":"2025-02-26 17:30","pubTimestamp":1740562241,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学(300869)02月26日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司未来是否有计划开发人形机器人家庭护理或者陪护类相关的产品?康泰医学董秘:尊敬的投资者您好,目前公司聚焦主营业务发展,持续深耕现有核心业务领域,致力于通过技术创新和产品优化为客户创造长期价值。公司始终对市场前沿技术的应用持积极和开放的态度,会密切关注人形机器人及家庭服务场景相关技术的发展趋势及应用情况,并积极寻找适合的业务机会。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600030774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2512142517","title":"康泰医学:公司在“互联网+医疗健康”领域不断探索合适的业务场景切入点","url":"https://stock-news.laohu8.com/highlight/detail?id=2512142517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512142517?lang=zh_cn&edition=full","pubTime":"2025-02-19 12:00","pubTimestamp":1739937646,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学(300869)02月18日在投资者关系平台上答复投资者关心的问题。投资者:公司在医疗器械方面虽然有一定地位,但也面临激烈竞争,今后是否考虑领先一步,向AI+医疗方面寻求发展及并购?康泰医学董秘:尊敬的投资者您好,近年来公司在“互联网+医疗健康”领域不断探索合适的业务场景切入点,开展了多项应用与尝试,公司在SaaS远程医疗平台的基础上,开展了AI与医疗设备相结合的预研工作,公司将继续关注AI技术的最新前沿进展。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900018019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","159792","BK0251","300869","160636"],"gpt_icon":0},{"id":"2512150198","title":"康泰医学新注册《CMS-ENMS心电及电生理网络管理系统软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2512150198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512150198?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:43","pubTimestamp":1739900623,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了2个项目的软件著作权,包括《CMS-ENMS心电及电生理网络管理系统软件V1.0》、《CMS-GS2可视喉镜软件V1.0》等。今年以来康泰医学新注册软件著作权110个,较去年同期增加了3566.67%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2512392591","title":"康泰医学:目前公司正在对相关产品进行考察","url":"https://stock-news.laohu8.com/highlight/detail?id=2512392591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512392591?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:00","pubTimestamp":1739869244,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学(300869)02月18日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司是否有计划引入deepseek模型应用到智能设备中?康泰医学董秘:尊敬的投资者您好,目前公司正在对相关产品进行考察,后续会根据市场发展趋势、项目实际需求以及技术应用的可行性等多方面因素,综合考虑是否接入DeepSeek或其他先进技术,以增强公司的技术实力,为消费者提供更好的医疗体验。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021800029195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2511619716","title":"康泰医学获得实用新型专利授权:“医疗支架装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511619716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511619716?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:16","pubTimestamp":1739560574,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康泰医学新获得一项实用新型专利授权,专利名为“医疗支架装置”,专利申请号为CN202323135068.4,授权日为2025年2月14日。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500007262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869","159891"],"gpt_icon":0},{"id":"2511619905","title":"康泰医学获得外观设计专利授权:“止痒仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511619905","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511619905?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:14","pubTimestamp":1739560499,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康泰医学新获得一项外观设计专利授权,专利名为“止痒仪”,专利申请号为CN202430365352.1,授权日为2025年2月14日。专利摘要:1.本外观设计产品的名称:止痒仪。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500006910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2511890619","title":"康泰医学获得实用新型专利授权:“吸奶器主机及吸奶器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511890619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511890619?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:09","pubTimestamp":1739560185,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示康泰医学新获得一项实用新型专利授权,专利名为“吸奶器主机及吸奶器”,专利申请号为CN202420887658.8,授权日为2025年2月14日。今年以来康泰医学新获得专利授权25个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500005607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2510893398","title":"康泰医学新注册《PM10便携式心电计软件V1.7》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2510893398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510893398?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:38","pubTimestamp":1739209093,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了2个项目的软件著作权,包括《PM10便携式心电计软件V1.7》、《CONTEC07A臂式电子血压计软件V1.1》等。今年以来康泰医学新注册软件著作权107个,较去年同期增加了3466.67%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100000427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2505220194","title":"康泰医学新注册《NE-M01VET兽用雾化器软件V1.4》等70个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2505220194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505220194?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:18","pubTimestamp":1737479895,"startTime":"0","endTime":"0","summary":"今年以来康泰医学新注册软件著作权105个,较去年同期增加了5150%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012200000655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2504548201","title":"康泰医学:预计2024年全年扣非后净利润亏损7400万元至1.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504548201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504548201?lang=zh_cn&edition=full","pubTime":"2025-01-17 20:07","pubTimestamp":1737115663,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学发布业绩预告,预计2024年全年扣非后净利润亏损7400万元至1.25亿元。康泰医学2024年三季报显示,公司主营收入3.34亿元,同比下降45.91%;归母净利润990.29万元,同比下降94.92%;扣非净利润-645.69万元,同比下降103.53%;其中2024年第三季度,公司单季度主营收入1.22亿元,同比下降0.53%;单季度归母净利润173.58万元,同比下降85.81%;单季度扣非净利润-260.33万元,同比下降125.79%;负债率31.74%,投资收益1536.07万元,财务费用-368.11万元,毛利率49.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011700041125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2504156405","title":"康泰医学(300869.SZ)发预亏,预计2024年度净亏损5500万元–1.05亿元,由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2504156405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504156405?lang=zh_cn&edition=full","pubTime":"2025-01-17 19:37","pubTimestamp":1737113873,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布2024年度业绩预告,公司预计2024年度归属于上市公司股东的净亏损5,500万元–1.05亿元,由盈转亏;扣除非经常性损益后的净亏损7,400万元–1.25亿元,由盈转亏。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2504155297","title":"康泰医学:预计2024年净利润亏损5500万元–1.05亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504155297","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504155297?lang=zh_cn&edition=full","pubTime":"2025-01-17 19:26","pubTimestamp":1737113173,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2503536976","title":"康泰医学新注册《康泰SP770VET兽用输液泵嵌入式软件V1.0》等12个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2503536976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503536976?lang=zh_cn&edition=full","pubTime":"2025-01-14 01:51","pubTimestamp":1736790668,"startTime":"0","endTime":"0","summary":"今年以来康泰医学新注册软件著作权33个,较去年同期增加了3200%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011400001159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2502309818","title":"康泰医学新注册《康泰PM20便携式心电计嵌入式软件V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2502309818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502309818?lang=zh_cn&edition=full","pubTime":"2025-01-11 01:58","pubTimestamp":1736531890,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了3个项目的软件著作权,包括《康泰PM20便携式心电计嵌入式软件V1.0》、《康泰BC300半自动生化分析仪嵌入式软件V1.2》、《康泰ECG100G心电图机嵌入式软件V1.1》等。今年以来康泰医学新注册软件著作权17个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011100003802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2502855309","title":"康泰医学最新公告:收到美国伊利诺伊北区联邦地区法院出具的《约定的永久禁令与撤诉令》","url":"https://stock-news.laohu8.com/highlight/detail?id=2502855309","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502855309?lang=zh_cn&edition=full","pubTime":"2025-01-10 18:39","pubTimestamp":1736505562,"startTime":"0","endTime":"0","summary":"康泰医学公告,公司及全资子公司美国康泰于近日收到美国伊利诺伊北区联邦地区法院出具的《约定的永久禁令与撤诉令》裁定。根据该裁定,在2025年12月31日之前,若康泰与北京超思双方未提出案件恢复审理申请,则本案将禁止再次提起相同诉讼,无需法院进一步行动。公司已升级涉诉被指控或提及的产品功能,且美国康泰已停止相关产品在美国销售,本次裁定结果不会对公司生产经营产生不利影响。裁定对公司本期利润或期后利润的具体影响需结合《和解协议》最终履行情况确定。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011000034761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2501282780","title":"康泰医学新注册《康泰超声骨密度仪PC软件V1.0》等4个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2501282780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501282780?lang=zh_cn&edition=full","pubTime":"2025-01-08 01:16","pubTimestamp":1736270172,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了4个项目的软件著作权,包括《康泰超声骨密度仪PC软件V1.0》、《康泰SP100肺功能仪嵌入式软件V2.0》、《康泰CIS1000输注站嵌入式软件V1.0》、《康泰HC10/HC20家用制氧机嵌入式软件V1.0》等。今年以来康泰医学新注册软件著作权14个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800000425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2501279250","title":"康泰医学新注册《康泰SP100A/SP100B肺功能仪嵌入式软件V3.4》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2501279250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501279250?lang=zh_cn&edition=full","pubTime":"2025-01-07 01:21","pubTimestamp":1736184069,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰SP100A/SP100B肺功能仪嵌入式软件V3.4》项目的软件著作权。今年以来康泰医学新注册软件著作权10个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010700000601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2501943771","title":"康泰医学新注册《康泰AP100空气波按摩仪嵌入式软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2501943771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501943771?lang=zh_cn&edition=full","pubTime":"2025-01-05 01:08","pubTimestamp":1736010494,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了2个项目的软件著作权,包括《康泰AP100空气波按摩仪嵌入式软件V1.0》、《康泰CMS600P2VET B型超声诊断设备嵌入式软件V2.0》等。今年以来康泰医学新注册软件著作权2个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了5605.5万元,同比增8.85%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010500000045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1743861426215,"stockEarnings":[{"period":"1week","weight":0.0232},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.1096},{"period":"6month","weight":-0.1217},{"period":"1year","weight":-0.1354},{"period":"ytd","weight":0.0459}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0407},{"period":"6month","weight":0.0017},{"period":"1year","weight":0.0889},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"35014人(较上一季度减少1.46%)","perCapita":"7235股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}